This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
AFTER NEARLY 3 years of investigation, the US Department of Health and Human Services' Office of Research Integrity (ORI) has dismissed all scientific misconduct charges against Bernard Fisher, MD, former head of the National Surgical Adjuvant Breast and Bowel Project (NSABP), and 2 colleagues.
Fisher Guided Study
As chair of the project and principal investigator for nearly 3 decades, Fisher, who is Distinguished Service Professor of Surgery at the University of Pittsburgh School of Medicine, Pittsburgh, Pa, guided the international study that has helped shift the treatment of breast cancer for many women from mastectomy to lumpectomy combined with subsequent radiation therapy.In 1994, following pressure from Rep John Dingell (D, Mich), the National Cancer Institute (NCI)—the principal sponsor of the NSABP—charged Fisher, Lawrence Wickerham, MD, adjunct research associate professor of surgery at Pittsburgh, and Carol Redmond, ScD, currently on leave from her professorship of biostatistics at Pittsburgh's Graduate
Skolnick AA. Breast Cancer Researchers Cleared of Charges. JAMA. 1997;277(12):950. doi:10.1001/jama.1997.03540360018006